Creative Biogene Leaps Into Actions on 2019-nCoV Diagnostic Kits

New York, USA – An ongoing outbreak of a novel coronavirus (SARS-CoV-2) has raised global concerns, and Creative Biogene, as a leading provider of genomics and proteomics products and services, releases 2019-nCoV Diagnostic Kits to help overcome this epidemic.

A novel coronavirus (SARS-CoV-2) originally detected in Wuhan, China, has caused an outbreak of viral pneumonia spreading to all provinces of China and lots of countries. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infections, patients with SARS-CoV-2 also exhibited symptoms of viral pneumonia including fever, dyspnea, bilateral lung infiltration, respiratory failure, even death.

So far, unprecedented efforts and dedication have been devoted to defeating this deadly infectious disease. With great passion to address difficulties, Creative Biogene leaps into actions on providing professional diagnostic products – 2019-nCoV Diagnostic Kits.

“Reverse Transcription-Polymerase Chain Reaction combines reverse transcription of RNA and polymerase chain amplification of cDNA.” Introduced by a senior scientist of Creative Biogene, “this technology is sensitive and versatile, and can be used to detect gene expression levels or RNA virus content in cells. Thus, it’s often used for virus detection.”

Diagnostic capability is key to the rapid detection of viruses and control of epidemic development. On February 4, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to allow the Centers for Disease Control and Prevention’s (CDC) emergency use of the real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) diagnostic reagents. While Creative Biogene has developed the real-time RT-PCR assay for COVID-19. The final etiology diagnosis of COVID-19 is necessary, which can be further confirmed by positive real-time RT-PCR assay for COVID-19.

The 2019-nCoV Real Time PCR Kits in Creative Biogene include:

• SARS-CoV-2/2019-nCoV ORF1ab gene Real Time PCR Kit
• SARS-CoV-2/2019-nCoV E gene Real Time PCR Kit
• SARS-CoV-2/2019-nCoV ORF1ab/N gene Real Time PCR Kit
• SARS-CoV-2/2019-nCoV N/E gene Real Time PCR Kit
• SARS-CoV-2/2019-nCoV ORF1ab/N/E gene Real Time PCR Kit
• SARS-CoV-2/2019-nCoV/Influenza A virus/Influenza B virus Real Time PCR Kit

These kits provided by Creative Biogene are fast and simple to operate with high specificity and accuracy. Samples such as alveolar lavage fluid, sputum, nasal and throat swabs can all be used for test.

Apart from the SARS-CoV-2 Diagnostic Kits, Creative Biogene, supported by experienced in-house scientists and first-in-class technological platform, also excels in Cell Assay Kits, Cloning Kits, Direct PCR Kits, Gene Editing Kits, Nucleic Acid Kits, etc., covering the whole field of molecular biology.

To prevent the spread of SARS-CoV-2, all available resources should be used to expedite the review of medical products, including diagnostic reagents. Creative Biogene is one of the forces committed to improving the global capacity to detect and respond to the 2019 novel coronavirus.

Further information can be found on

About Creative Biogene

Empowered by leading technology and years of experience in biomedical science, Creative Biogene is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industries.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-619-7922
Country: United States